Jefferies Raises Price Target on Ceragon Networks (CRNT) to $2.50
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/10/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Pre-Open Stock Movers 11/14: (CRBP) (HAR) (DGII) (MENT) Higher; (DVAX) (HEAR) (ACM) Lower (more...)
November 14, 2016 9:24 AM ESTToday's Pre-Open Stock Movers
Dynavax Technologies (Nasdaq: DVAX) 70.7% LOWER; announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for immunization of adults 18 years and older against hepatitis B infection. The FDA issues CRLs to communicate that the Agency has completed a review cycle of an application and to request additional information for review and approval. Dynavax expects a Class 2 designation for a... More
Ceragon Networks (CRNT) Reports In-Line Q3 EPS
November 14, 2016 8:42 AM ESTCeragon Networks (NASDAQ: CRNT) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $79.1 million versus the consensus estimate of $77.57 million.
For earnings history and earnings-related data on Ceragon Networks (CRNT) click here.
... MoreTrading Radar for 11/14: InterOil (IOC), Patriot National (PN), Netlist (NLST), Zoe's Kitchen (ZOES) Report
November 11, 2016 1:33 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.71
Abraxas Petroleum (Nasdaq: AXAS) - consensus loss $0.03
Akers Biosciences (Nasdaq: AKER) - no Street consensus
Aldeyra Therapeutics (Nasdaq: ALDX) - consensus loss $0.39
Amaya (NYSE: AYA) - consensus EPS $0.40
Asure Software (Nasdaq: ASUR) - consensus EPS... More
